The author of today’s article notes that, every year at the J.P. Morgan Healthcare Conference, “big mergers and acquisitions, as well as important clinical trial data and lucrative licensing deals, are announced. Healthcare stocks move sharply on the news coming out of the conference.” As with everything since COVID-19 took hold last March, however, this year’s conference was different, taking place virtually without a lot of major news dropping. As a result, the author advises that “there are lots of catalysts still out there waiting to happen” – and he has some advice on how to profit. For more, CLICK HERE.
How To Profit In A Different Landscape For Biotech Catalysts
- by RobH